Deckers' stock rises as sales of Hoka sneakers keep climbing
By Claudia Assis
Hoka, Ugg maker Deckers Outdoor's stock gains more than 7% on earnings beat
Deckers Outdoor Corp., maker of hit Hoka sneakers and in-again Ugg boots, zoomed past Wall Street's expectations for its fiscal fourth quarter, thanks to big sales gains for the two shoe brands, and the stock rallied more than 7% after hours.
Deckers (DECK) earned $127.5 million, or $4.95 a share, in the quarter, compared with $91.8 million, or $3.46 a share, in the year-ago period. Analysts polled by FactSet expected earnings of $2.97 a share.
Hoka and Ugg "remain two of the most admired and well-positioned brands in the marketplace," Chief Executive Dave Powers said in a statement.
Revenue jumped 21% to $960 million, compared with $792 million a year ago. That included a 34% quarter-on-quarter rise in Hoka sales, and a 15% increase in Ugg sales, partially offset by a 16% decline in Teva sales.
Deckers also raised its guidance for fiscal 2025, calling for sales to increase by about 10% to $4.7 billion, up from a previous expectation of sales of around $4.15 billion.
It guided for per-share earnings between $29.50 and $30 for the year, compared with an earlier expectation of EPS between $26.25 and $26.50.
Analysts polled by FactSet expect Deckers to report EPS of $30.47 on sales of $4.7 billion for the year.
-Claudia Assis
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-23-24 1656ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks